申请人:McDevitt Robert E.
公开号:US20070203120A1
公开(公告)日:2007-08-30
The present invention is directed to compounds of Formula I:
which are modulators of the 5-hydroxtryptamine-6 and 5-hydroxytryptamine-2A receptors and which are inhibitors of norepinephrine reuptake. The compounds of the invention, and pharmaceutical composition thereof, are useful in the treatment of disorders related to or associated with the 5-hydroxytryptamine-6 and 5-hydroxtryptamine-2A receptors or with norepinephrine reuptake inhibition.
本发明涉及式I的化合物:它们是5-羟色胺-6和5-羟色胺-2A受体的调节剂,同时也是去甲肾上腺素再摄取抑制剂。本发明的化合物及其制药组合物在治疗与5-羟色胺-6和5-羟色胺-2A受体或去甲肾上腺素再摄取抑制有关或相关的疾病方面是有用的。